Kardigan, Inc.
NASDAQ:KARDBiotechnology
+$0.77 today
- Market cap
- $1.10B
- Beta
- 0.00
Volume 0.55M
Average 5.84M
KARD Net Margin
Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.
Net Margin history
Percent of revenue · from the income statement
No Net Margin data reported for this period type.
Net Margin vs competitors
How KARD compares with its peers on the latest reported figures
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| FY2025 | -411.9% | — | — | |
| LTM Jun 2026 | -1259.9% | -552.7 pp | -480.4 pp | |
| LTM Jun 2026 | -3644.2% | -3385.3 pp | -883.7 pp | |
| LTM Mar 2026 | -36891.1% | — | — | |
| — | — | — | — | |
| FY2025 | — | — | — | |
| Peer median (excluding KARD) | -2452.0% | -1969.0 pp | -682.0 pp | |
Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Kardigan, Inc.
NASDAQ:KARD
Intrinsic Alpha fair value
Locked
Current Price
$12.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.